Ftse Mib
33.573,41
-0,40%
DAX
18.155,24
-0,04%
S&P 500
5.466,36
-0,05%
NASDAQ
17.755,17
0,21%
Bitcoin
61.045,13
-1,24%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ DMK Pharmaceuticals Corporation (DMK) DMK Pharmaceuticals Corporation (DMK) Notizie

DMK

DMK Pharmaceuticals (DMK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DMK
DataOraFonteTitoloSimboloCompagnia
21/03/202419:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
07/02/202423:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
06/02/202416:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
23/01/202423:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
21/12/202314:15GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHINASDAQ:DMKDMK Pharmaceuticals Corporation
28/11/202314:05GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
14/11/202313:30GlobeNewswire Inc.DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
13/11/202316:52GlobeNewswire Inc.DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023NASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202321:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202321:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
30/10/202312:30GlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
19/10/202322:05GlobeNewswire Inc.DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of GrowthNASDAQ:DMKDMK Pharmaceuticals Corporation
17/10/202318:28Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNASDAQ:DMKDMK Pharmaceuticals Corporation
12/10/202322:22Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
02/10/202322:49Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
26/09/202314:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
07/09/202318:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:DMKDMK Pharmaceuticals Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DMK

La tua Cronologia

COIN
GEMETH
USOTC
MONRF
Moncler (PK)
USOTC
ARNNY
ASR Nederland NV (PK)
BIT
UC612D
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network